Valiera ဆေး

Valiera ဆေးက ဘာအတွက်ကောင်းတာပါလဲ ဆက်သောက်ရင်ဆိုးကျိုးရော ရှိနိုင်ပါသလားရှင့်။ ကျွန်မ အသက်က ၄၇ အပျိုကြီးပါ။

အမျိုးသမီးတွေ သွေးဆုံးချိန်မှာ ဖြစ်ပေါ်ခံစားရတာတွေကို သက်သာစေအောင်ပေးတဲ့ စားဆေးဖြစ်တယ်။ အကြောင်းတခုခုကြောင့် အီစထိုဂျင်ဟော်မုန်းနည်းသွားသူတွေကိုလည်း ပေးတယ်။

Treatment of moderate to severe vasomotor symptoms associated with menopause. There is no comparable evidence that estrogens affect the neurologic or depressive symptoms commonly associated with menopause, so treatment is not indicated in these cases.

Treatment of vulvar and vaginal atrophy.

Treatment of cases of decreased estrogen secretion due to hypogonadism, oophorectomy or primary ovarian insufficiency.

Treatment of androgen-dependent advanced prostate carcinoma (temporary use only)

Prevention of osteoporosis.

Dosage

In the treatment of moderate to severe symptoms of vasomotor disorders, vulvar and vaginal atrophy in menopause should be initiated with the lowest therapeutic dose and selected regimens that can control these symptoms. and then discontinue as soon as possible: Discontinuation or dose reduction should occur at intervals of 3 to 6 months. The usual starting dose per day is ½ tablet -1 tablet of VALIERA 2 mg, depending on the patient's degree of control of existing symptoms. The minimum effective maintenance dose should be determined by titration (increase the dose slowly until the effective dose is reached, use it as the maintenance dose). Dosing should be carried out in cycles (eg, taking for 3 weeks, stopping for 1 week). 

- Treatment of women with decreased estrogen secretion due to hypogonadism, oophorectomy or primary ovarian insufficiency: The usual starting dose is ½ tablet -1 tablet of VALIERA 2mg, depending on the degree of control of symptoms. existing symptoms of the patient. The minimum effective maintenance dose should be determined by titration.

- Treatment of advanced androgen-dependent prostate cancer: The recommended dose is ½ tablet-1 tablet of VALIERA 2mg, 3 times a day. The effectiveness of the treatment regimen can be assessed by determining the amount of phosphatase as well as the improvement of the patient's symptoms.

- Osteoporosis prevention: Osteoporosis prophylaxis with VALIERA 2mg should be started as soon as possible after menopause. The daily dose is 0.5mg estrdiol, orally cyclically (ie, taken for 23 days, stopped for 5 days) (recommended VALIERA 1mg, 1/2 tablet/day.

Contraindications:

Pregnant or suspected to be pregnant. Estrogen can harm an unborn baby when administered to a pregnant mother.

Abnormal vaginal bleeding of unknown cause.

Identify or suspect breast, cervical or other gynecological cancers.

Known or suspected estrogen-dependent tumors.

The patient has a family history of gynecological cancer.

Progressive thrombophlebitis or thromboembolic disease.

Severe liver, kidney or heart disease.

ဒေါက်တာတင့်ဆွေ